March 4, 2013 - Atlanta, GA. The U.S. Women and PrEP Working Group, a coalition of more than 50 women from leading AIDS and women’s health organizations, today called on US government agencies to coordinate a national agenda that will quickly and accurately answer questions about how the antiretroviral (ARV) drug Truvada can best be made available as an HIV prevention option for women at risk of HIV infection. Continue Reading...
Do you get our newsletter?
Sign up for our monthly Newsletter and get the latest info in you in box.
Learn how HIV and HIV drugs can affect the menstrual cycle, what else can cause menstrual problems, and how to deal with these problems.
Get basic information about hormones, how HIV and HIV drugs can affect hormone levels, and different ways to treat shortages of hormones.